janhartmannmd.bsky.social
Bringing Med to MedTech - Physician, Scientist, Photographer, Traveler, Berliner, Immigrant 🇩🇪🇺🇸 - Views=My own, Like/RT≠Endorsement; Haemonetics employee
👤 Joined on 11 November 2024
Followers
Following
Total Posts
@janhartmannmd.bsky.socialPeripheral arterial disease (PAD) affects more than 300 million people worldwide—yet it remains under-recognised, underdiagnosed, and undertreated. A new Editorial discusses a Lancet Series aiming to address this major health burden: spkl.io/633207pL2I
Show PostPeripheral arterial disease (PAD) affects more than 300 million people worldwide—yet it remains under-recognised, underdiagnosed, and undertreated. A new Series aims to address this major health burden: spkl.io/633217rwP1
Show PostAn expert panel established consensus clinical criteria to adjudicate the presence of actionable hemorrhage in chart review of injured children https://www.ovid.com/jnls/jtrauma/abstract/10.1097/ta.0000000000004958~consensus-based-criteria-for-actionable-hemorrhage-in?redirectionsource=fulltextview
Show Post“The discovery of orexins & their link to narcolepsy became central for understanding sleep–wake regulation itself.” 🧪Sebastiaan Overeem & Birgitte R. Kornum report in @nejm.org on the pivotal roles that #LaskerAward winners Mignot & Yanagisawa had in the discovery of orexin: buff.ly/T3CPftu
Show PostIn patients with severe aortic stenosis and coronary artery disease, a strategy of transcatheter aortic-valve implantation before percutaneous coronary intervention was noninferior to PCI before TAVI for major clinical events at 1 year. Full TAVI PCI results: https://nej.md/3SlY3SF #ESCCongress
Show Post